Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04498520
Title Abexinostat, Palbociclib, and Fulvestrant for the Treatment of Breast or Gynecologic Cancer
Recruitment Not yet recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Pamela Munster

peritoneum cancer

fallopian tube cancer

ovary epithelial cancer

endometrial cancer

Her2-receptor negative breast cancer


Abexinostat + Fulvestrant + Palbociclib

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.